Search
Close this search box.
    • Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Investor Contact

Financial Institutions, Brokerage Firms and Financial

Krishnan G

Head – Investor Relations

Corporate Governance, Shareholder Grievance Redressal & Retail Shareholders

Priyadarshini mahapatra

Company Secretary & Compliance Officer
(Nodal Officer – IEPF)

Registrar and Share Transfer Agents

KFin Technologies Limited

Selenium Tower B, Plot 31 & 32,Financial District, Nanakramguda, Serilingampally Mandal,Hyderabad – 500 032, Telangana.

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details